Large-scale merger and acquisition eyed among small- and medium-sized wholesalers

Stimulated by the prevailing business recession, movement of pharmaceutical firms towards wholesaler's margin reduction, fierce competition and more strict administrative regulations on drug prices, small- and medium-sized are struggling with their survival via large-scale merger and acquisition.

Reportedly, three or four drug wholesalers with annual turnover of 50.0 billion won in Seoul are...